These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38213143)

  • 1. Disulfidptosis-related Protein RPN1 may be a Novel Anti-osteoporosis Target of Kaempferol.
    Pan C; Zhang C; Lin Z; Liang Z; Cui Y; Shang Z; Wei Y; Chen F
    Comb Chem High Throughput Screen; 2024; 27(11):1611-1628. PubMed ID: 38213143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology analysis and experimental validation to explore the mechanism of kaempferol in the treatment of osteoporosis.
    Dong Q; Ren G; Li Y; Hao D
    Sci Rep; 2024 Mar; 14(1):7088. PubMed ID: 38528143
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wang X; Zhu HQ; Lin SM; Xia BY; Xu B
    Transl Cancer Res; 2024 May; 13(5):2518-2534. PubMed ID: 38881923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of the disulfidptosis-related gene
    Zong Y; Zhu A; Liu P; Fu P; Li Y; Chen S; Gao X
    Heliyon; 2024 Jun; 10(11):e31875. PubMed ID: 38845861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol promotes BMSC osteogenic differentiation and improves osteoporosis by downregulating miR-10a-3p and upregulating CXCL12.
    Liu H; Yi X; Tu S; Cheng C; Luo J
    Mol Cell Endocrinol; 2021 Jan; 520():111074. PubMed ID: 33157164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA sequencing-based approaches to identifying disulfidptosis-related diagnostic clusters and immune landscapes in osteoporosis.
    Zhang P; Li B; Chen H; Ge Z; Shang Q; Liang D; Yu X; Ren H; Jiang X; Cui J
    Aging (Albany NY); 2024 May; 16(9):8198-8216. PubMed ID: 38738994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of disulfidptosis and periodontitis: New insights and clinical significance.
    Fan Y; Liu W; Qi L; Zhao Q; Li S; Zou H; Kong C; Li Z; Ren J; Liu Z; Wang B
    Arch Oral Biol; 2024 Oct; 166():106046. PubMed ID: 38991331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol promotes bone formation in part via the mTOR signaling pathway.
    Zhao J; Wu J; Xu B; Yuan Z; Leng Y; Min J; Lan X; Luo J
    Mol Med Rep; 2019 Dec; 20(6):5197-5207. PubMed ID: 31638215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of genes co-associated with osteoporosis and chronic HBV infection based on bioinformatics analysis and machine learning.
    Yang J; Yang W; Hu Y; Tong L; Liu R; Liu L; Jiang B; Sun Z
    Front Immunol; 2024; 15():1472354. PubMed ID: 39351238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the diagnostic and immune infiltration roles of disulfidptosis related genes in pulmonary hypertension.
    Tan X; Zhang N; Zhang G; Xu S; Zeng Y; Bian F; Tang B; Wang H; Fan J; Bo X; Fu Y; Fan H; Zhou Y; Kang P
    Respir Res; 2024 Oct; 25(1):365. PubMed ID: 39385167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and immunogenicity of bone marrow-derived mesenchymal stem cells under osteoporotic conditions.
    Huang Y; Yin Y; Gu Y; Gu Q; Yang H; Zhou Z; Shi Q
    Sci China Life Sci; 2020 Mar; 63(3):429-442. PubMed ID: 31879847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mijiao formula regulates NAT10-mediated Runx2 mRNA ac4C modification to promote bone marrow mesenchymal stem cell osteogenic differentiation and improve osteoporosis in ovariectomized rats.
    Xiao D; Huang S; Tang Z; Liu M; Di D; Ma Y; Li Y; Duan JA; Lu C; Zhao M
    J Ethnopharmacol; 2024 Aug; 330():118191. PubMed ID: 38621468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin promotes osteogenic differentiation of mesenchymal stem cells in rat model of osteoporosis through BMP-2/Smads signaling pathway.
    Feng C; Xiao L; Yu JC; Li DY; Tang TY; Liao W; Wang ZR; Lu AQ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):434-443. PubMed ID: 31957858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
    Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology.
    Long SW; Li SH; Li J; He Y; Tan B; Jing HH; Zheng W; Wu J
    BMC Med Genomics; 2024 Apr; 17(1):99. PubMed ID: 38650009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis.
    Wang X; Pei Z; Hao T; Ariben J; Li S; He W; Kong X; Chang J; Zhao Z; Zhang B
    Front Immunol; 2022; 13():987937. PubMed ID: 36311708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of Sambucus williamsii Hance var. miquelii in the treatment of osteoporosis analyzed by UHPLC-HRMS/MS combined network pharmacology and experimental validation.
    Mu L; Gao J; Zhang Q; Kong F; Lian Y; Li X; Ma Z; Sun Q
    Fitoterapia; 2024 Jul; 176():106003. PubMed ID: 38729247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GGCX on the differentiation function of osteoporosis bone marrow mesenchymal stem cells through regulating TGFβ/smad signaling pathway.
    Wang QL; Li HF; Wang DP; Liu ZY; Xiao WW; Xu LL; Yu S
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7224-7231. PubMed ID: 31539109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo efficacy studies of layer-by-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: a study in ovariectomized rat model.
    Kumar A; Gupta GK; Khedgikar V; Gautam J; Kushwaha P; Changkija B; Nagar GK; Gupta V; Verma A; Dwivedi AK; Chattopadhyay N; Mishra PR; Trivedi R
    Eur J Pharm Biopharm; 2012 Nov; 82(3):508-17. PubMed ID: 22926146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs.
    Liang G; Zhao J; Pan J; Yang Y; Dou Y; Yang W; Zeng L; Liu J
    J Orthop Surg Res; 2023 Apr; 18(1):312. PubMed ID: 37087476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.